Category
- Tobii Group
- Interim report
July 25, 2017
Tobii AB today reported its results for the second quarter and first six months 2017. During the second quarter, Tobii made a number of strategic product launches and a business acquisition.
Comment by Tobii’s CEO Henrik Eskilsson:
“We launched a large number of exciting and strategically important products in the second quarter. I am very proud of our solid development efforts and the overall positive response from customers which confirms our product strategy. Other highlights were Tobii Pro’s strong sales performance and the acquisition of Sticky.”
April – June
January – June
Significant events
Conference call
Today at 2:00 p.m. Tobii will host a conference call with web cast presentation for media, analyst and investors. Please find dial-in details on Tobii’s website under Interim Report Q2 2017.
This information is information that Tobii AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, on July 25, 2017, at 8:00 a.m. CET.
Tobii is the global leader in eye tracking and pioneer of attention computing. Creating tech for a better future, our technologies and solutions apply to areas such as behavioral studies and research, healthcare, education and training, gaming, extended reality, automotive, and many more. Headquartered in Sweden, Tobii is listed on Nasdaq Stockholm (TOBII). For more information: www.tobii.com.
July 25, 2017
Head of Investor Relations
+46 (0)72 219 82 15
Interim Head of Communications, Tobii
Tobii is the global leader in eye tracking and pioneer of attention computing. Creating tech for a better future, our technologies and solutions apply to areas such as behavioral studies and research, healthcare, education and training, gaming, extended reality, automotive, and many more. Headquartered in Sweden, Tobii is listed on Nasdaq Stockholm (TOBII). For more information: www.tobii.com.